The emerging role of transcranial magnetic resonance imaging–guided focused ultrasound in functional neurosurgery

Movement Disorders

Volumn 32, Issue 1, 2017, Pages 20-27

  Weintraub, David ^a   Elias, W Jeffrey ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

blood brain barrier; essential tremor; focused ultrasound; functional neurosurgery; minimally invasive surgery; neuromodulation; obsessive compulsive disorder; Parkinson's disease

Indexed keywords

ANXIETY DISORDER; BLOOD BRAIN BARRIER; CLINICAL TRIAL (TOPIC); DEPRESSION; ECHOGRAPHY; ESSENTIAL TREMOR; FUNCTIONAL NEUROIMAGING; HUMAN; MINIMALLY INVASIVE SURGERY; NEUROMODULATION; NEUROPATHIC PAIN; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; THALAMOTOMY; THERMAL INJURY; TRANSCRANIAL MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND; ULTRASOUND TRANSDUCER; ANIMAL; COMPUTER ASSISTED SURGERY; HIGH INTENSITY FOCUSED ULTRASOUND; NEUROLOGIC DISEASE; PROCEDURES; TRENDS;

ANIMALS; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; NEUROSURGICAL PROCEDURES; SURGERY, COMPUTER-ASSISTED;

EID: 84963784593     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26599     Document Type: Review

References (71)

1. Rezai AR, Machado AG, Deogaonkar M, Azmi H, Kubu C, Boulis NM. Surgery for movement disorders. Neurosurgery 2008;62(Suppl 2):809-838; discussion, 838-809.
2. Benabid AL, Chabardes S, Torres N, et al. Functional neurosurgery for movement disorders: a historical perspective. Prog Brain Res 2009;175:379-391.
3. Hariz MI, Blomstedt P, Zrinzo L. Deep brain stimulation between 1947 and 1987: the untold story. Neurosurg Focus 2010;29:E1.
4. Cooper IS. Chemopallidectomy: an investigative technique in geriatric parkinsonians. Science 1955;121:217-218.
5. Cooper IS. Neurosurgical alleviation of intention tremor of multiple sclerosis and cerebellar disease. N Engl J Med 1960;263:441-444.
6. Fry FJ, Ades HW, Fry WJ. Production of reversible changes in the central nervous system by ultrasound. Science 1958;127:83-84.
7. Fry WJ, Fry FJ, Barnard JW, Krumins RF, Brennan JF, Fry WJ. Ultrasonic lesions in mammalian central nervous system. Science 1955;122:1091-1091.
8. Fry WJ, Mosberg WH, Barnard JW, Fry FJ. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 1954;11:471-478.
9. Narabayashi H, Shimazu H, Fujita Y, Shikiba S, Nagao T, Nagahata M. Procaine-oil-wax pallidotomy for double athetosis and spastic states in infantile cerebral palsy: report of 80 cases. Neurology 1960;10:61-61.
10. Sweet WH, Mark VH, Hamlin H. Radiofrequency lesions in the central nervous system of man and cat. J Neurosurg 1960;17:213-225.
11. Meyers R, Fry FJ, Fry WJ, Eggleton RC, Schultz DF. Determination of topologic human brain representations and modifications of signs and symptoms of some neurologic disorders by the use of high level ultrasound. Neurology 1960;10:271-271.
12. Meyers R, Fry WJ, Fry FJ, Dreyer LL, Schultz DF, Noyes RF. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg 1959;16:32-54.
13. Medel R, Monteith SJ, Elias WJ, et al. Magnetic resonance-guided focused ultrasound surgery: part 2: a review of current and future applications. Neurosurgery 2012;71:755-763.
14. Hynynen K, Clement GT, McDannold N, et al. 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med 2004;52:100-107.
15. Clement GT, Hynynen K. A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol 2002;47:1219-1236.
16. Clement GT, Hynynen K. Correlation of ultrasound phase with physical skull properties. Ultrasound Med Biol 2002;28:617-624.
17. Sun J, Hynynen K. The potential of transskull ultrasound therapy and surgery using the maximum available skull surface area. J Acoust Soc Am 1999;105:2519-2527.
18. Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med 1995;34:814-823.
19. Chang WS, Jung HH, Kweon EJ, Zadicario E, Rachmilevitch I, Chang JW. Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes. J Neurol Neurosurg Psychiatry 2014;86:257-264.
20. Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640-648.
21. Lipsman N, Schwartz ML, Huang Y, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 2013;12:462-468.
22. Schlesinger I, Eran A, Sinai A, et al. MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson's disease. Parkinsons Dis 2015;2015:219149.
23. Jung HH, Chang WS, Rachmilevitch I, Tlusty T, Zadicario E, Chang JW. Different magnetic resonance imaging patterns after transcranial magnetic resonance–guided focused ultrasound of the ventral intermediate nucleus of the thalamus and anterior limb of the internal capsule in patients with essential tremor or obsessive-compulsive disorder. J Neurosurg 2015;122:162-168.
24. Jung HH, Kim SJ, Roh D, et al. Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessive-compulsive disorder: a proof-of-concept study. Mol Psychiatry 2015;20:1205-1211.
25. Jeanmonod D, Werner B, Morel A, et al. Transcranial magnetic resonance imaging–guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus 2012;32:E1.
26. Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B. High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol 2009;66:858-861.
27. Eames MD, Hananel A, Snell JW, Kassell NF, Aubry JF. Trans-cranial focused ultrasound without hair shaving: feasibility study in an ex vivo cadaver model. J Ther Ultrasound 2013;1:24.
28. Pinton G, Aubry JF, Bossy E, Muller M, Pernot M, Tanter M. Attenuation, scattering, and absorption of ultrasound in the skull bone. Med Phys 2012;39:299-307.
29. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011;77:1752-1755.
30. Louis ED. Treatment of essential tremor: are there issues we are overlooking? Front Neurol 2011;2:91.
31. Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol 2011;10:148-161.
32. Benito-Leon J, Louis ED. Clinical update: diagnosis and treatment of essential tremor. Lancet 2007;369:1152-1154.
33. Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2016;375:730-739.
34. Wintermark M, Druzgal J, Huss DS, et al. Imaging findings in MR imaging-guided focused ultrasound treatment for patients with essential tremor. AJNR Am J Neuroradiol 2014;35:891-896.
35. Magara A, Bühler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease. J Ther Ultrasound. 2014;2:11.
36. Jung HH, Chang WS, Rachmilevitch I, Tlusty T, Zadicario E, Chang JW. Different magnetic resonance imaging patterns after transcranial magnetic resonance-guided focused ultrasound of the ventral intermediate nucleus of the thalamus and anterior limb of the internal capsule in patients with essential tremor or obsessive-compulsive disorder. J Neurosurg 2015;122:162-168.
37. Na YC, Chang WS, Jung HH, Kweon EJ, Chang JW. Unilateral magnetic resonance-guided focused ultrasound pallidotomy for Parkinson disease. Neurology 2015;85:549-551.
38. A feasibility clinical trial of the management of the medically-refractory dyskinesia symptoms of advanced idiopathic Parkinson's disease with unilateral lesioning of the globus pallidum using the ExAblate transcranial system. National Library of Medicine (US). 2000 (cited 2015 Oct 31). Available at: http://clinicaltrials.gov/show/NCT02263885 NLM identifier: NCT02263885. Accessed 31 October 2015.
39. Feasibility trial evaluating the safety and efficacy of ExAblate transcranial magnetic resonance guided focused ultrasound (MRgFUS) for unilateral pallidotomy for the treatment of L-dopa induced dyskinesia (LID) of Parkinson's disease. National Library of Medicine (US). 2000 [cited 2015 Oct 31]. Available at: http://clinicaltrials.gov/show/NCT02347254. NLM identifier: NCT02347254. Accessed 31 October 2015.
40. A feasibility study to evaluate safety and initial effectiveness of ExAblate transcranial MR guided focused ultrasound for unilateral pallidotomy in the treatment of dyskinesia of Parkinson's disease. National Library of Medicine (US). 2000 [cited 2015 Oct 31]. Available at: http://clinicaltrials.gov/show/NCT02003248. NLM identifier: NCT02003248. Accessed 31 October 2015.
41. A feasibility study to evaluate safety and initial effectiveness of ExAblate transcranial MR guided focused ultrasound for unilateral thalamotomy in the treatment of medication-refractory tremor dominant idiopathic Parkinson's disease. National Library of Medicine (US). 2000 (cited 2015 Oct 31). Available at: http://clinicaltrials.gov/show/NCT01772693 NLM Identifier: NCT01772693. Accessed 31 October 2015.
42. A feasibility clinical trial of the management of the medically-refractory motor symptoms of advanced idiopathic Parkinson's disease with staged, unilateral lesioning of the subthalamic nucleus using the ExAblate transcranial system. National Library of Medicine (US). 2000 (cited 2015 Oct 31). Available at: http://clinicaltrials.gov/show/NCT02246374 NLM Identifier: NCT02246374. Accessed 31 October 2015.
43. Lopes AC, Greenberg BD, Canteras MM, et al. Gamma ventral capsulotomy for obsessive-compulsive disorder. JAMA Psychiatry 2014;71:1066-1076.
44. Kondziolka D, Flickinger JC, Hudak R. Results following gamma knife radiosurgical anterior capsulotomies for obsessive compulsive disorder. Neurosurgery 2011;68:28-33.
45. Sheehan JP, Patterson G, Schlesinger D, Xu Z. Gamma knife surgery anterior capsulotomy for severe and refractory obsessive-compulsive disorder. J Neurosurg 2013;119:1112-1118.
46. Alonso P, Cuadras D, Gabriëls L, et al. Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response. PLoS One 2015;10:e0133591.
47. Hamani C, Pilitsis J, Rughani AI, et al. Deep brain stimulation for obsessive-compulsive disorder: systematic review and evidence-based guideline sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and endorsed by the CNS and American Association of Neurological Surgeons. Neurosurgery 2014;75:327-333; quiz, 333.
48. Mian MK, Campos M, Sheth SA, Eskandar EN. Deep brain stimulation for obsessive-compulsive disorder: past, present, and future. Neurosurg Focus 2010;29:E10.
49. A feasibility study to evaluate safety and initial effectiveness of ExAblate transcranial MR guided focused ultrasound for bilateral anterior capsulotomy in the treatment of medication-refractory MDD. National Library of Medicine (US). 2000 (cited 2015 Oct 31). Available at: http://clinicaltrials.gov/show/NCT02348411 NLM identifier: NCT02348411. Accessed 31 October 2015.
50. Ballantine HT, Jr., Bell E, Manlapaz J. Progress and problems in the neurological applications of focused ultrasound. J Neurosurg 1960;17:858-876.
51. Tyler WJ, Tufail Y, Finsterwald M, Tauchmann ML, Olson EJ, Majestic C. Remote excitation of neuronal circuits using low-intensity, low-frequency ultrasound. PLoS One 2008;3:e3511.
52. Krasovitski B, Frenkel V, Shoham S, Kimmel E. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc Natl Acad Sci U S A 2011;108:3258-3263.
53. Tufail Y, Matyushov A, Baldwin N, et al. Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron 2010;66:681-694.
54. Deffieux T, Younan Y, Wattiez N, Tanter M, Pouget P, Aubry JF. Low-intensity focused ultrasound modulates monkey visuomotor behavior. Curr Biol 2013;23:2430-2433.
55. Legon W, Sato TF, Opitz A, et al. Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans. Nat Neurosci 2014;17:322-329.
56. Lee W, Kim H, Jung Y, Song IU, Chung YA, Yoo SS. Image-guided transcranial focused ultrasound stimulates human primary somatosensory cortex. Sci Rep 2015;5:8743.
57. Ibsen S, Tong A, Schutt C, Esener S, Chalasani SH. Sonogenetics is a non-invasive approach to activating neurons in Caenorhabditis elegans. Nat Commun 2015;6:8264.
58. Vykhodtseva N, McDannold N, Hynynen K. Progress and problems in the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics 2008;48:279-296.
59. Neuwelt EA, Maravilla KR, Frenkel EP, Rapaport SI, Hill SA, Barnett PA. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest 1979;64:684-688.
60. Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E. Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 1983;12:662-671.
61. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. Proceedings of the National Academy of Sciences U S A 1994;91:2076-2080.
62. Bakay L, Ballantine HT, Jr., Hueter TF, Sosa D. Ultrasonically produced changes in the blood-brain barrier. AMA Arch Neurol Psychiatry 1956;76:457-467.
63. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging–guided focal opening of the blood-brain barrier in rabbits. Radiology 2001;220:640-646.
64. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A 2006;103:11719-11723.
65. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006;340:1085-1090.
66. Wei KC, Tsai HC, Lu YJ, et al. Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swine. Am J Neuroradiol 2012;34:115-120.
67. Wei KC, Chu PC, Wang HY, et al. Focused ultrasound-induced blood–brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS One 2013;8:e58995.
68. A study to evaluate the safety and feasibility of blood-brain barrier disruption using transcranial MRI-guided focused ultrasound with intravenous ultrasound contrast agents in the treatment of brain tumours with doxorubicin. National Library of Medicine (US). 2000 (cited 2015 Oct 31). Available at: http://clinicaltrials.gov/show/NCT02343991 NLM identifier: NCT02343991. Accessed 31 October 2015.
69. Jordão JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-β plaque load in the TgCRND8 mouse model of Alzheimer's disease. PLoS One 2010;5:e10549.
70. Burgess A, Dubey S, Yeung S, et al. Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology 2014;273:736-745.
71. Leinenga G, Götz J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Sci Transl Med 2015;7:278ra233.